Discover 1,972 paid clinical trials in Miramar, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,972
Bioaerosol Sampling Device (BSD) Clinical Study
for
COVID-19
Location: Pembroke Pines FL, Hollywood FL, Humble TX, Houston TX,
Sponsor: Cantor BioConnect, Inc.
Sex: All
Age: 5+
Code: NCT06047067
Recruiting
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
for
Crohn Disease
Location: Miami Lakes FL, Miami FL, Atlanta GA, Kingwood TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07483099
Phase 2, Recruiting
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
for
Colitis, Ulcerative, Crohn Disease
Location: Miami Lakes FL, Miami FL, Atlanta GA, Kingwood TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07483073
Phase 2, Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
for
Systemic Lupus Erythematosus
Location: Cooper City FL, Plantation FL, Homestead FL, Tampa FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06133972
Phase 3, Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
for
Schizophrenia
Location: Cooper City FL, Hollywood FL, Lauderhill FL, Miami FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 55
Code: NCT07410507
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
for
Immune Thrombocytopenia
Location: Cooper City FL, Fairfax VA, The Bronx NY, New Haven CT,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07104565
Phase 2, Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)